Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 89

1.

The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate.

Tortola L, Nitsch R, Bertrand MJ, Kogler M, Redouane Y, Kozieradzki I, Uribesalgo I, Fennell LM, Daugaard M, Klug H, Wirnsberger G, Wimmer R, Perlot T, Sarao R, Rao S, Hanada T, Takahashi N, Kernbauer E, Demiröz D, Superti-Furga G, Decker T, Pichler A, Ikeda F, Kroemer G, Vandenabeele P, Sorensen PH, Penninger JM.

Cell Rep. 2016 May 17;15(7):1481-92. doi: 10.1016/j.celrep.2016.04.032. Epub 2016 May 5.

2.

Multiple scattering in grazing-incidence X-ray diffraction: impact on lattice-constant determination in thin films.

Resel R, Bainschab M, Pichler A, Dingemans T, Simbrunner C, Stangl J, Salzmann I.

J Synchrotron Radiat. 2016 May;23(Pt 3):729-34. doi: 10.1107/S1600577516003672. Epub 2016 Apr 20.

3.

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.

Pleyer L, Burgstaller S, Stauder R, Girschikofsky M, Sill H, Schlick K, Thaler J, Halter B, Machherndl-Spandl S, Zebisch A, Pichler A, Pfeilstöcker M, Autzinger EM, Lang A, Geissler K, Voskova D, Geissler D, Sperr WR, Hojas S, Rogulj IM, Andel J, Greil R.

J Hematol Oncol. 2016 Apr 16;9:39. doi: 10.1186/s13045-016-0263-4.

4.

Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.

Pinter D, Beckmann C, Koini M, Pirker E, Filippini N, Pichler A, Fuchs S, Fazekas F, Enzinger C.

PLoS One. 2016 Mar 23;11(3):e0152158. doi: 10.1371/journal.pone.0152158. eCollection 2016.

5.

Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.

Khalil M, Renner A, Langkammer C, Enzinger C, Ropele S, Stojakovic T, Scharnagl H, Bachmaier G, Pichler A, Archelos JJ, Fuchs S, Seifert-Held T, Fazekas F.

Mult Scler. 2016 Jan 13. pii: 1352458515624560. [Epub ahead of print]

PMID:
26762671
6.

Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke.

Traylor M, Zhang CR, Adib-Samii P, Devan WJ, Parsons OE, Lanfranconi S, Gregory S, Cloonan L, Falcone GJ, Radmanesh F, Fitzpatrick K, Kanakis A, Barrick TR, Moynihan B, Lewis CM, Boncoraglio GB, Lemmens R, Thijs V, Sudlow C, Wardlaw J, Rothwell PM, Meschia JF, Worrall BB, Levi C, Bevan S, Furie KL, Dichgans M, Rosand J, Markus HS, Rost N; International Stroke Genetics Consortium.

Neurology. 2016 Jan 12;86(2):146-53. doi: 10.1212/WNL.0000000000002263. Epub 2015 Dec 16.

7.

Structural basis for catalytic activation by the human ZNF451 SUMO E3 ligase.

Cappadocia L, Pichler A, Lima CD.

Nat Struct Mol Biol. 2015 Dec;22(12):968-75. doi: 10.1038/nsmb.3116. Epub 2015 Nov 2.

8.

A new vertebrate SUMO enzyme family reveals insights into SUMO-chain assembly.

Eisenhardt N, Chaugule VK, Koidl S, Droescher M, Dogan E, Rettich J, Sutinen P, Imanishi SY, Hofmann K, Palvimo JJ, Pichler A.

Nat Struct Mol Biol. 2015 Dec;22(12):959-67. doi: 10.1038/nsmb.3114. Epub 2015 Nov 2.

PMID:
26524493
9.

Population data analysis of dissolution time profiles: Assessment of physicochemical properties of the drug, drug particles and the pharmaceutical formulation.

Horkovics-Kovats S, Brunovský P, Pichler A, Bulitta JB.

Eur J Pharm Sci. 2015 Oct 12;78:245-54. doi: 10.1016/j.ejps.2015.07.017. Epub 2015 Jul 26.

PMID:
26215465
10.

Combined analysis of global and compartmental brain volume changes in early multiple sclerosis in clinical practice.

Pichler A, Khalil M, Langkammer C, Pinter D, Bachmaier G, Ropele S, Fuchs S, Enzinger C, Fazekas F.

Mult Scler. 2016 Mar;22(3):340-6. doi: 10.1177/1352458515593405. Epub 2015 Jul 10.

PMID:
26163072
11.

Periventricular lesions correlate with cortical thinning in multiple sclerosis.

Jehna M, Pirpamer L, Khalil M, Fuchs S, Ropele S, Langkammer C, Pichler A, Stulnig F, Deutschmann H, Fazekas F, Enzinger C.

Ann Neurol. 2015 Oct;78(4):530-9. doi: 10.1002/ana.24461. Epub 2015 Jul 28.

PMID:
26084936
12.

Surgical treatment of mandibular condyle fractures using the retromandibular anterior transparotid approach and a triangular-positioned double miniplate osteosynthesis technique: A clinical and radiological evaluation of 124 fractures.

Dalla Torre D, Burtscher D, Widmann G, Pichler A, Rasse M, Puelacher W.

J Craniomaxillofac Surg. 2015 Jul;43(6):944-9. doi: 10.1016/j.jcms.2015.04.019. Epub 2015 Apr 30.

PMID:
26027860
13.

Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.

Khalil M, Langkammer C, Pichler A, Pinter D, Gattringer T, Bachmaier G, Ropele S, Fuchs S, Enzinger C, Fazekas F.

Neurology. 2015 Jun 16;84(24):2396-402. doi: 10.1212/WNL.0000000000001679. Epub 2015 May 15.

PMID:
25979698
14.

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial.

Machiels JP, Haddad RI, Fayette J, Licitra LF, Tahara M, Vermorken JB, Clement PM, Gauler T, Cupissol D, Grau JJ, Guigay J, Caponigro F, de Castro G Jr, de Souza Viana L, Keilholz U, Del Campo JM, Cong XJ, Ehrnrooth E, Cohen EE; LUX-H&N 1 investigators.

Lancet Oncol. 2015 May;16(5):583-94. doi: 10.1016/S1470-2045(15)70124-5. Epub 2015 Apr 16.

PMID:
25892145
15.

Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.

Pinter D, Khalil M, Pichler A, Langkammer C, Ropele S, Marschik PB, Fuchs S, Fazekas F, Enzinger C.

Neuroimage Clin. 2015 Mar 5;7:715-20. doi: 10.1016/j.nicl.2015.02.023. eCollection 2015.

16.

Music therapy in cancer patients: fact or fiction?

Pichler A, Pichler M.

Future Oncol. 2014 Dec;10(15):2409-11. doi: 10.2217/fon.14.181. No abstract available.

17.

Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy.

Gattringer T, Enzinger C, Khalil M, Schwingenschuh P, Pichler A, Moser A, Graninger W, Ernst C, Haybaeck J, Fazekas F.

Neurol Neuroimmunol Neuroinflamm. 2014 Apr 24;1(1):e1. doi: 10.1212/NXI.0000000000000001. eCollection 2014 Jun. No abstract available.

18.

Polypharmacy and chronic pain: harm exposure is not all about the opioids.

Giummarra MJ, Gibson SJ, Allen AR, Pichler AS, Arnold CA.

Pain Med. 2015 Mar;16(3):472-9. doi: 10.1111/pme.12586. Epub 2014 Oct 3.

19.

Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study.

Rocca MA, Valsasina P, Hulst HE, Abdel-Aziz K, Enzinger C, Gallo A, Pareto D, Riccitelli G, Muhlert N, Ciccarelli O, Barkhof F, Fazekas F, Tedeschi G, Arévalo MJ, Filippi M; MAGNIMS fMRI Study Group.

Hum Brain Mapp. 2014 Dec;35(12):5799-814. doi: 10.1002/hbm.22586. Epub 2014 Jul 18.

PMID:
25045065
20.

Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.

Loitfelder M, Fazekas F, Koschutnig K, Fuchs S, Petrovic K, Ropele S, Pichler A, Jehna M, Langkammer C, Schmidt R, Neuper C, Enzinger C.

PLoS One. 2014 Apr 9;9(4):e93715. doi: 10.1371/journal.pone.0093715. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk